Nanotechnology Now - Press Release: New Report Provides an in-Depth Discussion on Recent Developments of Nanoparticle Enabled Drug Delivery Systems (DDS) and Future Opportunities

Home > Press > New Report Provides an in-Depth Discussion on Recent Developments of Nanoparticle Enabled Drug Delivery Systems (DDS) and Future Opportunities

Abstract:
Research and Markets
( http://www.researchandmarkets.com/reports/c68525 ) has announced the addition of Nanoparticle Drug Delivery Market Report to their offering.

New Report Provides an in-Depth Discussion on Recent Developments of Nanoparticle Enabled Drug Delivery Systems (DDS) and Future Opportunities

DUBLIN, Ireland | Posted on September 14th, 2007

This report will give Pharma investors a comprehensive understanding on the impact of nanotechnologies on the pharmaceutical market and companies, which include companies that are producing nanomaterials/technologies to enable better drug delivery compounds (drug delivery company) and companies that are using nano-enabled formulations to enhance drug delivery (drug formulation company).

This report will provide an in-depth discussion on recent developments of nanoparticle enabled drug delivery systems (DDS) and future opportunities. It is tailored for investors who plan to invest in the pharmaceutical industry with an eye towards how nanoparticle drug delivery technology will impact the economics of the pharmaceutical market.

The information includes business summaries, technology core competencies, how nanoparticle adds value for investors in drug delivery companies, commercialization strategies, intellectual property and available markets.

There are 58 case studies on nanoparticle DDS listed according to 3 categories:

-Delivery Method/Routes of administration

Oral administration

Transdermal delivery

Injectable delivery

Topical delivery

Inhaled/nasal/pulmonary delivery

Implantable delivery

-Therapeutics

Cancer therapy

Vaccines

Antibody

DNA-based therapy

-Technology

Nanoparticulate encapsulation

Dendrimer-based targeted therapeutics technology

Liposomes nanotechnology

Nanotube technologies

Nanoparticles coating technology

Silica-chitosan nanocomposite

Nanosome technology

We provide a nanotechnology model based on primary research quantifying the impact and diffusion of nanotechnologies by industry sector over time. The model takes into account global R&D spending on nanotechnologies and assumes a median seven year time lag between the start of a funding program and a commercially useful output, industry R&D growth rates, global GDP growth predictions and the rate of penetration of nanotechnologies based on primary research to develop the rate of diffusion by industry sector.

Content Outline:

EXECUTIVE SUMMARY

AIM, SCOPE AND ORGANIZATION OF REPORT

CIENTIFICA NANOTECHNOLOGY MODEL

Definitions of Nanotechnologies

Major Assumptions

BACKGROUND

MARKET FORECAST & OVERVIEW

INTRODUCTION TO THE MARKETS

NANOPHARMACEUTICALS

NANOTECHNOLOGY IN DRUG DELIVERY

NANOBIOTECHNOLOGY IN DRUG DELIVERY

OTHER APPLICATIONS FOR NANOMATERIALS IN THE MEDICAL AND PHARMACEUTICAL SECTOR

TRENDS AND NEEDS

ROADMAP

NANOTECHNOLOGY INFLUENCE IN PHARMACEUTICAL VALUE CHAIN

ANALYTICAL TECHNIQUES FOR NANOPARTILE DRUG DELIVERY

NANOPARTICLES AS DRUG CARRIERS

PROJECTED PRODUCT PIPELINE FOR NANOPARTICLE IN DRUG DELIVERY MARKET

DRUG DELIVERY CHALLENGES -- WHY DRUG DELIVERY & WHY NANOPARTICLES

THE NEED FOR BETTER DRUG THERAPY

THE NEED FOR DRUG SOLUBILITY

THE NEED FOR SITE-SPECIFIC AND ORGAN-SPECIFIC IN FUNCTION

DRIVERS AND OPPORTUNITIES FOR NANOPARTICLE DRUG DELIVERY

THE AIM OF DRUG TARGETING

REASONS WHY THE DRUG DELIVERY MARKET IS RAPIDLY EXPANDING

MARKET DRIVERS FOR ENHANCED DRUG DELIVERY

THE ADVANTAGES OF USING POLYMERIC NANOPARTICLES (PNPS) IN DRUG DELIVERY

EXPANDING GOVERNMENTAL FUNDING DRIVES THE NANOBIOTECHNOLOGY MARKET

HOW DRUG COMPANIES ARE REACTING TO THIS EXPANSION

FUTURE BARRIERS AND CHALLENGES

BIG PHARMACEUTICAL COMPANIES RELUCTANT TO INVEST IN UNTRIED TECHNOLOGIES

LACK OF REGULATORY CASE LAW

LONG ADMISSION PROCEDURES INCLUDING FOR EXAMPLE SEVERAL CLINICAL TRIALS

A NEED FOR RAPID SCREENING METHODS

SCALABILITY OF NANOPARTICLE PRODUCTION

AN URGENT NEED FOR ANALYTICAL METHODS

A NEED FOR THE INVESTIGATION OF FURTHER NANOPARTICLES

THE POTENTIAL TOXICITY OF ENGINEERED NANOPARTICLES IS AN UNSOLVED ISSUE AND STILL NEEDS TO BE DEALT WITH

THE FUTURE OF NANO AND BIO COLLABORATIONS IS PROMISING

NANOPARTICLE ADDED VALUE IN DRUG DELIVERY

CASE STUDY -- UNIVERSITY OF MICHIGAN'S NANOPARTICLE-BASED PAIN RELIEF STUDY FOR MILITARY BATTLEFIELD USE

CASE STUDY -- ACUSPHERE'S HYDROPHOBIC DRUG DELIVERY SYSTEM (HDDS™) FOR

REFORMULATION OF HYDROPHOBIC DRUGS

CASE STUDY -- IMARX'S HYDROPLEX™ PLATFORM FOR DELIVERING HYDROPHOBIC DRUGS

CASE STUDY - ALPHARX'S NANOPARTICLE DRUG DELIVERY PLATFORM FOR ANTIBIOTIC DRUGS

CASE STUDY - CYTRX'S RNAI NANOPARTICLE DELIVERY TECHNOLOGY FOR RNAI THERAPEUTICS

INVESTING IN NANOPARTCLE-ENABLED DRUG DELIVERY INDUSTRY

CASE STUDY - NANOTHERAPEUTICS' COMMERCIALISATION STRATEGY

CASE STUDY - HOW CAN NANOVINDEX'S NANOPARTICLE HYDROGEL COMPOSITES ADD VALUE FOR

DRUG DELIVERY INVESTORS

CASE STUDY -- KEYSTONE NANO'S MOLECULAR DOTS (MDS) COMMERCIALISATION STRATEGY

CASE STUDY - NANOCARRIER'S PROTEINS NANOENCAPSULATION SEEKING OUT BIG BIOTECH BUSINESS

CASE STUDY -- NANOBIOMAGNETICS' BUSINESS MODEL FOR ORGAN-ASSISTING-DEVICE (OAD)

TECHNOLOGIES

CASE STUDY - HOW CAN AVIDIMER THERAPEUTICS' AVIDIMERS PLATFORM TECHNOLOGY ADD VALUE FOR DRUG DELIVERY INVESTORS

CASE STUDY -- CAPSULUTION'S COMMERCIALISATION STRATEGY FOR LBL-TECHNOLOGY®-BASED

DRUG DELIVERY SYSTEMS

CASE STUDY -- ACCESS PHARMACEUTICALS' PRODUCT PIPELINE FOR COBALAMIN™- MEDIATED

DISEASE TARGETING

CASE STUDY - AZAYA THERAPEUTICS' PRODUCT PIPELINE FOR PROTEIN STABILIZED LIPOSOME (PSL™)

NANOTECHNOLOGY

NANOPARTICLE DRUG DELIVERY SYSTEM BY DELIVERY METHOD/ROUTES OF

ADMINISTRATION

DELIVERY METHOD

ORAL ADMINISTRATION

TRANSDERMAL DELIVERY

INJECTABLE DELIVERY

TOPICAL DELIVERY

INHALED/NASAL/PULMONARY DELIVERY

IMPLANTABLE DELIVERY

NANOPARTICLE DRUG DELIVERY SYSTEM BY THERAPEUTICS

THERAPY

CANCER THERAPY

VACCINES

ANTIBODY

DNA BASED THERAPY

NANOPARTICLE DRUG DELIVERY SYSTEM BY TECHNOLOGY

NANOPARTICULATE ENCAPSULATION

THE DENDRIMER-BASED TARGETED THERAPEUTICS TECHNOLOGY

LIPOSOMES NANOTECHNOLOGY

NANOTUBE TECHNOLOGIES

NANOSHELL TECHNOLOGY

NANOPARTICLES COATING TECHNOLOGY

SILICA-CHITOSAN NANOCOMPOSITE

NANOCRYSTAL TECHNOLOGY

NANOSOME TECHNOLOGY

NANOSUSPENSION TECHNOLOGY

POLYMER THERAPEUTICS

APPENDIX 1: LIST OF NANOPARTICLE DRUG DELIVERY PLATFORMS/TECHNOLOGIES

APPENDIX 2: NANOPARTICLES IN DRUG DELIVERY PRODUCTS ON THE MARKET OR IN CLINICAL PHASE 1/2/3

APPENDIX 3: OVERVIEW OF NANOPARTICLE APPLICATIONS IN DRUG DELIVERY

APPENDIX 4: DRUG DELIVERY COMPANY - COMPANIES WHO PRODUING

NANOPARTICLES/TECHNOLOGIES ENABLE BETTER DRUG DELIVERY COMPOUNDS

APPENDIX 5: DRUG FORMULATION COMPANY - COMPANIES WHO USING

NANOPARTICLE-ENABLED FORMULATIONS TO ENHANCE DRUG DELIVERY

Table of Exhibits

####

About Research and Markets
We are the leading source for international market research and market data. We hold ‘000’s of major research publications from most of the leading publishers, consultants and analysts. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends

We are a ‘One-Stop-Shop’ for market research reports and industry newsletters from specialist research firms and niche market analysts.

For more information, please click here

Contacts:
Research and Markets
Laura Wood, Senior Manager
Fax: +353 1 4100 980

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: